A personal risk assessment
Genetic Technologies' test products identify the personal genetic risk of developing a specific disease.
Personalised genetic risk profile
Based on a patient’s risk profile, a healthcare provider will be empowered to recommend more frequent screening, medication or lifestyle changes.
​
Genetic risk assessment helps individuals and their healthcare provider develop personalised health management plans to promote early detection and treatment of disease.
Roadmap
Q4 2019
Early 2020 pipeline
Mid 2020
Breast Cancer*
Colorectal Cancer*
Prostate Cancer
Melanoma
*Tests are developed and market launch is scheduled for Q1 2020
BREVAGenplus
Our first to market, clinically validated genetic risk assessment for non-hereditary (sporadic) breast cancer.
GeneType
for Breast Cancer
A personalised breast cancer risk assessment test
GeneType
for Colorectal Cancer
A personalised colorectal cancer risk assessment test